PPARA and metabolic dysfunction-associated steatohepatitis: In the context of liver pathology, PPARα was demonstrated to be a direct target of miR-155 or miR-21 in mouse biliary, hepatic and inflammatory cells in a mouse model of alcohol-induced steatohepatitis, NASH and in the development of hepatocellular carcinoma (HCC) [13,34,35,37].